General form of registration statement for all companies including face-amount certificate companies

SCHEDULE OF REVENUE RECOGNITION (Details) (Parenthetical)

v3.24.2.u1
SCHEDULE OF REVENUE RECOGNITION (Details) (Parenthetical) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]            
Revenue $ 2,397,652 $ 19,738 $ 4,804,043 $ 20,659 $ 2,532,499 $ 4,803
Health Care, Patient Service [Member]            
Product Information [Line Items]            
Revenue     4,209,955 [1] [1] $ 2,199,558 [2] [2]
Health Care, Patient Service [Member] | CyPath® Lung [Member]            
Product Information [Line Items]            
Revenue     $ 199,000      
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $199,000.
[2] Patient services fees includes direct billing for CyPath® Lung diagnostic test.